Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Pharmacological Reviews
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Pharmacological Reviews

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit Pharm Rev on Facebook
  • Follow Pharm Rev on Twitter
  • Follow ASPET on LinkedIn
Review ArticleReview

International Union of Pharmacology. XXXIV. Lysophospholipid Receptor Nomenclature

Jerold Chun, Edward J. Goetzl, Timothy Hla, Yasuyuki Igarashi, Kevin R. Lynch, Wouter Moolenaar, Susan Pyne and Gabor Tigyi
Pharmacological Reviews June 2002, 54 (2) 265-269; DOI: https://doi.org/10.1124/pr.54.2.265
Jerold Chun
1 2 3 4 5 6 7 8
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Edward J. Goetzl
1 2 3 4 5 6 7 8
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Timothy Hla
1 2 3 4 5 6 7 8
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yasuyuki Igarashi
1 2 3 4 5 6 7 8
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kevin R. Lynch
1 2 3 4 5 6 7 8
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wouter Moolenaar
1 2 3 4 5 6 7 8
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Susan Pyne
1 2 3 4 5 6 7 8
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gabor Tigyi
1 2 3 4 5 6 7 8
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

The lysophospholipids, lysophosphatidic acid (LPA) and sphingosine 1-phosphate (S1P), are now recognized as important extracellular signaling molecules. These lipid mediators are pleiotropic; among the most common cellular responses are mitogenesis, cell survival (anti-apoptosis), inhibition of adenylyl cyclase and calcium mobilization. Physiologic events associated with these mediators include platelet aggregation, vasopressor activity, wound healing, immune modulation, and angiogenesis. Many of the actions of LPA and S1P are mediated through a set of eight G protein-coupled receptors. Five of these are S1P-prefering while the remaining three are LPA receptors. These receptors are expressed widely and in aggregate signal through a variety of heterotrimeric G proteins. The lysophospholipid receptor family is referred to commonly as the “Edg” group (e.g., Edg-1, Edg-2, etc.). Herein, the molecular pharmacology of the lysophospholipid receptors is reviewed briefly, and a rational nomenclature for LPA and S1P receptors that is consistent with the International Union of Pharmacology guidelines is proposed.

  • The American Society for Pharmacology and Experimental Therapeutics
View Full Text
PreviousNext
Back to top

In this issue

Pharmacological Reviews: 54 (2)
Pharmacological Reviews
Vol. 54, Issue 2
1 Jun 2002
  • Table of Contents
  • About the Cover
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Pharmacological Reviews article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
International Union of Pharmacology. XXXIV. Lysophospholipid Receptor Nomenclature
(Your Name) has forwarded a page to you from Pharmacological Reviews
(Your Name) thought you would be interested in this article in Pharmacological Reviews.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Review ArticleReview

International Union of Pharmacology. XXXIV. Lysophospholipid Receptor Nomenclature

Jerold Chun, Edward J. Goetzl, Timothy Hla, Yasuyuki Igarashi, Kevin R. Lynch, Wouter Moolenaar, Susan Pyne and Gabor Tigyi
Pharmacological Reviews June 1, 2002, 54 (2) 265-269; DOI: https://doi.org/10.1124/pr.54.2.265

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Review ArticleReview

International Union of Pharmacology. XXXIV. Lysophospholipid Receptor Nomenclature

Jerold Chun, Edward J. Goetzl, Timothy Hla, Yasuyuki Igarashi, Kevin R. Lynch, Wouter Moolenaar, Susan Pyne and Gabor Tigyi
Pharmacological Reviews June 1, 2002, 54 (2) 265-269; DOI: https://doi.org/10.1124/pr.54.2.265
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • I. Introduction
    • II. Discovery of Lysophospholipid Receptors
    • III. Receptor Nomenclature
    • IV. Nonhuman Lysophospholipid Receptors
    • V. Lysophospholipid Receptor Ligands
    • VI. Lysophospholipid Receptor Gene Knockouts
    • VII. Lysophospholipid Receptor Expression
    • VIII. Conclusion
    • Footnotes
    • Abbreviations
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • RNA Interference in Biology and Medicine
  • Induction of Drug Metabolism: The Role of Nuclear Receptors
  • International Union of Pharmacology. XXXIX. Compendium of Voltage-Gated Ion Channels: Sodium Channels
Show more REVIEW

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Pharmacological Reviews
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacology Research & Perspectives
ISSN 1521-0081 (Online)

Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics